INAB Shares Outstanding History



Below is a table of the INAB shares outstanding history going back to 9/7/2021:

Date INAB Shares Outstanding
9/7/202118.75M
11/3/202118.75M
3/10/202218.81M
5/3/202218.84M
8/7/202218.84M
11/1/202224.50M
3/28/202324.94M
5/7/202329.75M
8/7/202331.60M
11/6/202331.99M

Also see: INAB Market Cap History
INAB YTD Return
INAB Historical Shares Outstanding:
+27.98% CAGR
INAB Historical Shares Outstanding: +27.98% CAGR

Mouse over chart for data details
9/7/2021 ...11/6/2023
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Co.'s clinical and preclinical product candidates are: INB-200, which is a genetically modified autologous gamma-delta T cell product in a Phase 1 clinical trial; INB-100, which is Co.'s allogeneic DeltEx product candidate that is being administered in a dose-escalation Phase 1 clinical trial for the treatment of patients with hematologic malignancies; and INB-400, which is in a Phase 2 clinical trial using Co.'s autologous DeltEx drug resistant immunotherapy product candidate to treat newly diagnosed glioblastoma. We show 10 historical shares outstanding datapoints in our coverage of INAB's shares outstanding history.

Understanding the changing numbers of INAB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like INAB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching INAB by allowing them to research INAB shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree INAB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
IN8bio (INAB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

INBS Shares Outstanding History
INBX Shares Outstanding History
INCY Shares Outstanding History
INDP Shares Outstanding History
INFI Shares Outstanding History
INGN Shares Outstanding History
INKT Shares Outstanding History
INMB Shares Outstanding History
INNT Shares Outstanding History
INNV Shares Outstanding History
More Healthcare companies »

 

INAB Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.